DA Davidson Maintains Neutral Rating for Usana Health Sciences: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
DA Davidson has maintained its Neutral rating for Usana Health Sciences (NYSE:USNA) but lowered its price target from $62.00 to $53.00. Shares of USNA are currently trading down 6.96% at $51.57 per share. A move to $53.00 would account for a 2.77% increase from the current share price.
October 25, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DA Davidson has maintained its Neutral rating for Usana Health Sciences but lowered its price target. This could potentially impact the stock's performance in the short term.
The lowering of the price target by DA Davidson could potentially lead to a decrease in the stock price of Usana Health Sciences in the short term. This is because the new price target is lower than the previous one, indicating a less optimistic outlook for the stock. Furthermore, the stock is currently trading down, which could be a reaction to this news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100